IL-7 Activates the Phosphatidylinositol 3-Kinase/AKT Pathway in Normal Human Thymocytes but Not Normal Human B Cell Precursors1

IL-7 signaling culminates in different biological outcomes in distinct lymphoid populations, but knowledge of the biochemical signaling pathways in normal lymphoid populations is incomplete. We analyzed CD127/IL-7Rα expression and function in normal (nontransformed) human thymocytes, and human CD19+ B-lineage cells purified from xenogeneic cord blood stem cell/MS-5 murine stromal cell cultures, to further clarify the role of IL-7 in human B cell development. IL-7 stimulation of CD34+ immature thymocytes led to phosphorylation (p-) of STAT5, ERK1/2, AKT, and glycogen synthase kinase-3 β, and increased AKT enzymatic activity. In contrast, IL-7 stimulation of CD34− thymocytes (that included CD4+/CD8+ double-positive, and CD4+ and CD8+ single-positive cells) only induced p-STAT5. IL-7 stimulation of CD19+ cells led to robust induction of p-STAT5, but minimal induction of p-ERK1/2 and p-glycogen synthase kinase-3 β. However, CD19+ cells expressed endogenous p-ERK1/2, and when rested for several hours following removal from MS-5 underwent de-phosphorylation of ERK1/2. IL-7 stimulation of rested CD19+ cells resulted in robust induction of p-ERK1/2, but no induction of AKT enzymatic activity. The use of a specific JAK3 antagonist demonstrated that all IL-7 signaling pathways in CD34+ thymocytes and CD19+ B-lineage cells were JAK3-dependent. We conclude that human CD34+ thymocytes and CD19+ B-lineage cells exhibit similarities in activation of STAT5 and ERK1/2, but differences in activation of the PI3K/AKT pathway. The different induction of PI3K/AKT may at least partially explain the different requirements for IL-7 during human T and B cell development.

[1]  L. Staudt,et al.  Characterization of early stages of human B cell development by gene expression profiling , 2009, The Journal of Immunology.

[2]  M. Munchhof,et al.  The specificity of JAK3 kinase inhibitors. , 2008, Blood.

[3]  J. Rathmell,et al.  IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. , 2008, Blood.

[4]  Lewis C. Cantley,et al.  AKT/PKB Signaling: Navigating Downstream , 2007, Cell.

[5]  L. Nelin,et al.  MAPK phosphatases — regulating the immune response , 2007, Nature Reviews Immunology.

[6]  R. Mazzucchelli,et al.  Interleukin-7 receptor expression: intelligent design , 2007, Nature Reviews Immunology.

[7]  N. Taylor,et al.  IL-7-induced proliferation of recent thymic emigrants requires activation of the PI3K pathway. , 2007, Blood.

[8]  M. Kondo,et al.  Developmental switch of mouse hematopoietic stem cells from fetal to adult type occurs in bone marrow after birth , 2006, Proceedings of the National Academy of Sciences.

[9]  M. Toribio,et al.  Notch1 and IL-7 Receptor Interplay Maintains Proliferation of Human Thymic Progenitors while Suppressing Non-T Cell Fates1 , 2006, The Journal of Immunology.

[10]  A. Cumano,et al.  Molecular and functional evidence for activity of murine IL-7 on human lymphocytes. , 2006, Experimental hematology.

[11]  N. Taylor,et al.  IL-7Rα Gene Expression Is Inversely Correlated with Cell Cycle Progression in IL-7-Stimulated T Lymphocytes1 , 2006, The Journal of Immunology.

[12]  P. Kaldis,et al.  IL-7 promotes T cell proliferation through destabilization of p27Kip1 , 2006, The Journal of experimental medicine.

[13]  C. Paige,et al.  IL-7: a key regulator of B lymphopoiesis. , 2006, Seminars in immunology.

[14]  D. Schatz,et al.  Origins of peripheral B cells in IL-7 receptor-deficient mice. , 2006, Molecular immunology.

[15]  A. Singer,et al.  Cytokine signal transduction is suppressed in preselection double-positive thymocytes and restored by positive selection , 2006, The Journal of experimental medicine.

[16]  T. Lebien,et al.  Murine and Human IL-7 Activate STAT5 and Induce Proliferation of Normal Human Pro-B Cells1 , 2005, The Journal of Immunology.

[17]  Marcel J. T. Reinders,et al.  Ig Gene Rearrangement Steps Are Initiated in Early Human Precursor B Cell Subsets and Correlate with Specific Transcription Factor Expression1 , 2005, The Journal of Immunology.

[18]  Q. Jiang,et al.  Cell biology of IL-7, a key lymphotrophin. , 2005, Cytokine & growth factor reviews.

[19]  J. Woodgett.  Recent advances in the protein kinase B signaling pathway. , 2005, Current opinion in cell biology.

[20]  J. V. van Dongen,et al.  Age-related changes in the cellular composition of the thymus in children. , 2005, The Journal of allergy and clinical immunology.

[21]  A. Fischer,et al.  Interleukin‐7 receptor α (IL‐7Rα) deficiency: cellular and molecular bases. Analysis of clinical, immunological, and molecular features in 16 novel patients , 2005, Immunological reviews.

[22]  I. Mårtensson,et al.  Impaired B‐1 and B‐2 B cell development and atypical splenic B cell structures in IL‐7 receptor‐deficient mice , 2004, European journal of immunology.

[23]  Thijs J. Hagenbeek,et al.  The Loss of PTEN Allows TCR αβ Lineage Thymocytes to Bypass IL-7 and Pre-TCR–mediated Signaling , 2004, The Journal of experimental medicine.

[24]  J. Barata,et al.  Activation of PI3K Is Indispensable for Interleukin 7–mediated Viability, Proliferation, Glucose Use, and Growth of T Cell Acute Lymphoblastic Leukemia Cells , 2004, The Journal of experimental medicine.

[25]  R. Buckley.  Molecular defects in human severe combined immunodeficiency and approaches to immune reconstitution. , 2004, Annual review of immunology.

[26]  B. Foxwell,et al.  A Late, Prolonged Activation of the Phosphatidylinositol 3-Kinase Pathway Is Required for T Cell Proliferation1 , 2004, The Journal of Immunology.

[27]  T. Chiles,et al.  Phosphatidylinositol 3-Kinase-Dependent Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase 1/2 and NF-κB Signaling Pathways Are Required for B Cell Antigen Receptor-Mediated Cyclin D2 Induction in Mature B Cells1 , 2004, The Journal of Immunology.

[28]  Doughty,et al.  Phosphatidylinositol 3-Kinase-Dependent Mitogen-Activated Protein/Extracellular Signal-Regulated Kinase Kinase 1/2 and NF- B Signaling Pathways Are Required for B Cell Antigen Receptor-Mediated Cyclin D2 Induction in Mature B Cells , 2004 .

[29]  I. Mårtensson,et al.  Complementary Signaling through flt3 and Interleukin-7 Receptor α Is Indispensable for Fetal and Adult B Cell Genesis , 2003, The Journal of experimental medicine.

[30]  J. O’Shea,et al.  Prevention of Organ Allograft Rejection by a Specific Janus Kinase 3 Inhibitor , 2003, Science.

[31]  A. Cumano,et al.  Thymic stromal-derived lymphopoietin distinguishes fetal from adult B cell development , 2003, Nature Immunology.

[32]  J. McCune,et al.  Effects of IL-7 on Early Human Thymocyte Progenitor Cells In Vitro and in SCID-hu Thy/Liv Mice1 , 2003, The Journal of Immunology.

[33]  A. Jacob,et al.  Convergence of Signaling Pathways on the Activation of ERK in B Cells* , 2002, The Journal of Biological Chemistry.

[34]  T. Fry,et al.  Interleukin-7: from bench to clinic. , 2002, Blood.

[35]  R. Koup,et al.  Effects of exogenous interleukin-7 on human thymus function. , 2002, Blood.

[36]  Eva Jiménez,et al.  Stromal cell-derived factor 1/CXCR4 signaling is critical for early human T-cell development. , 2002, Blood.

[37]  A. Cumano,et al.  Arrested B Lymphopoiesis and Persistence of Activated B Cells in Adult Interleukin 7−/− Mice , 2001, The Journal of experimental medicine.

[38]  H. Fleming,et al.  Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway. , 2001, Immunity.

[39]  J. Barata,et al.  Interleukin-7 promotes survival and cell cycle progression of T-cell acute lymphoblastic leukemia cells by down-regulating the cyclin-dependent kinase inhibitor p27(kip1). , 2001, Blood.

[40]  T. Lebien,et al.  Fates of human B-cell precursors. , 2000, Blood.

[41]  H. Spits,et al.  Distinct roles of the phosphatidylinositol 3-kinase and STAT5 pathways in IL-7-mediated development of human thymocyte precursors. , 1999, Immunity.

[42]  Y. Yazaki,et al.  Xid-like immunodeficiency in mice with disruption of the p85alpha subunit of phosphoinositide 3-kinase. , 1999, Science.

[43]  Steven F. Ziegler,et al.  Defective IL7R expression in T-B+NK + severe combined immunodeficiency , 1998, Nature Genetics.

[44]  F. Hobbs,et al.  Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase* , 1998, The Journal of Biological Chemistry.

[45]  J. Liesveld,et al.  Expression of interleukin-7 receptor by lineage-negative human bone marrow progenitors with enhanced lymphoid proliferative potential and B-lineage differentiation capacity. , 1997, Blood.

[46]  T. Lebien,et al.  Interleukin 7 independent development of human B cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[47]  M. Owen,et al.  The interleukin‐7 receptor alpha chain transmits distinct signals for proliferation and differentiation during B lymphopoiesis. , 1996, The EMBO journal.

[48]  W. Leonard,et al.  Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development , 1995, Science.

[49]  P. Doherty,et al.  Defective Lymphoid Development in Mice Lacking Jak3 , 1995, Science.

[50]  A. Sharpe,et al.  Defects in B Lymphocyte Maturation and T Lymphocyte Activation in Mice Lacking Jak3 , 1995, Science.

[51]  J. Johnston,et al.  Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID) , 1995, Nature.

[52]  S. Burdach,et al.  Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine , 1995, The Journal of experimental medicine.

[53]  W. Leonard,et al.  Defective lymphoid development in mice lacking expression of the common cytokine receptor gamma chain. , 1995, Immunity.

[54]  M. Toribio,et al.  The Development of T and Non-t Cell Lineages from Cd34 § Human Thymic Precursors Can Be Traced by the Differential Expression of Cd44 Materials and Methods , 1995 .

[55]  A. Fischer,et al.  Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor gamma chain. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[56]  T. Lebien,et al.  The growth response to IL-7 during normal human B cell ontogeny is restricted to B-lineage cells expressing CD34. , 1995, Journal of immunology.

[57]  C. Ware,et al.  Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice , 1994, The Journal of experimental medicine.

[58]  A. Venkitaraman,et al.  Interleukin‐7 induces the association of phosphatidylinositol 3‐kinase with the α chain of the interleukin‐7 receptor , 1994, European journal of immunology.

[59]  K Y Hui,et al.  A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). , 1994, The Journal of biological chemistry.

[60]  H. Spits,et al.  Precursors of CD3+CD4+CD8+ cells in the human thymus are defined by expression of CD34. Delineation of early events in human thymic development , 1993, The Journal of experimental medicine.

[61]  W. Leonard,et al.  Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans , 1993, Cell.

[62]  C. March,et al.  Stimulation of B-cell progenitors by cloned murine interleukin-7 , 1988, Nature.